Latest filing published 23 Sept 2016 for Sonnet BioTherapeutics Holdings, Inc., €2,248.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
J. Michael Carroll: trading record in brief
J. Michael Carroll is a declared insider of Sonnet BioTherapeutics Holdings, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 30 March 2011 to 23 September 2016, the count stands at 4 filings.
No open-market sale appears; the market trades are 1 purchase worth €2,248. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants. So far in 2016, the count stands at 1 purchase and no sales.
Most recently, on 23 September 2016, the filings show an open-market purchase worth €2,248 in Sonnet BioTherapeutics Holdings, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to J. Michael Carroll
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ US$0.63100.0% of flowCommon StockSEC:0001493152-16-013561:0Canonical exit: 22 Dec 2016 (T+90)
- 5,500 shares@ US$3.00Common StockSEC:0001493152-15-003264:0
- 10,000 shares@ US$1.73Common StockSEC:0001493152-15-003264:1
- 1,000 shares@ US$2.69Common StockSEC:0001493152-15-003264:2
4 of 4 declarations